A new imaging-based rapid in vivo toxicological screening method

Period of Performance: 08/01/2017 - 01/31/2018

$217K

Phase 1 SBIR

Recipient Firm

Theramix, LLC
MOUNTAIN VIEW, CA 94041
Principal Investigator

Abstract

Abstract This proposal aims to introduce a new imaging approach for fast toxicological screening and toxicity evaluation. Toxicity testing with animals has limitations with regards to cost, time, reliability, and animal welfare. However, the most challenging situation is that thousands of chemicals can?t be tested for safety assessment using existing testing methods. Of the USEPA list of 85,000 chemicals, only 2% of them have detailed safety data. Together with another approximately 700 new chemicals being introduced each year, the tremendous number of chemicals with unknown safety information pose a potentially serious threat to public health. In traditional animal testing, adverse effects of chemicals can typically only be detected after the onset of adverse health effects, disease or death in animals exposed to relatively high doses of the substance. Our new imaging approach detects real time damage at the cellular level in the animals exposed to test substances. Thus, the adverse effects can be monitored at any time as long as cellular damage occurs. It provides a rapid method for toxicological screening, and it becomes possible to test substances at environmentally- or biologically-relevant concentrations. Based on this imaging approach, we can develop new methods for large scale chemical testing. In this proposal, we will first demonstrate the ability of the imaging system to detect and identify sites of toxicity produced by well establish toxic chemicals. We will then explore the application of the imaging approach for acute toxicity testing.